media – Page 9 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

APAC Leadership Transition and Cyberattack Hits Full-Year Guidance

Boston Scientific announced that Arthur Butcher, EVP and Head of International MedSurg, will retire. Butcher joined in 1996, served as EVP & President of Asia Pacific from 2020-2022, and has led MedSurg & APAC Group since 2022 after over 30 years with the company. He will step down on January 1, 2027. Boston Scientific has also been recovering from a major cyberattack identified on August 25, 2026 that disrupted global operations. On September 8, the company stated the incident could materially impact Q3 and full-year results, and it expects to miss prior net sales growth and adjusted EPS guidance. This follows a July 29 guidance cut to 5%-6% organic growth due to slowing electrophysiology and Watchman momentum. Source: https://news.yaozh.com/archive/49062.html
- Source: drugdu
- 151
- September 29, 2026
Huadong Medicine Discloses Positive Top-line Results for Weight-loss Drug, Pipeline May Be Revalued

Huadong Medicine announced that its wholly-owned subsidiary Sino-American East China has achieved positive top-line results in the China Phase III trial (HDM1002-301) of its Class 1 innovative oral small-molecule GLP-1 receptor agonist HDM1002 tablets for weight management in overweight or obese individuals. All dosage groups met all primary and key secondary endpoints at week 44; continued treatment resulted in sustained weight loss further decreasing at week 52 without a plateau; significant improvements in cardiometabolic markers, substantial reduction in liver fat content, and optimized body composition were observed; safety and tolerability were consistent with the GLP-1 class with no new signals. The company has completed Pre-NDA communication and will soon submit a marketing application in China. Research institutions indicate the biopharmaceutical industry will benefit from upcoming policies, with related companies expected to see improved performance. Source: https://finance.eastmoney.com/a/202609283885024341.html
- Source: drugdu
- 144
- September 29, 2026
Core Product Velyso Granted Orphan Drug Designation in Japan

On September 28, Leads Biolabs-B (09887) announced that its core product Velyso® (opatidijumimab, a PD-L1/4-1BB bispecific antibody) has been granted orphan drug designation by the Japanese Ministry of Health, Labour and Welfare for the treatment of extrapulmonary neuroendocrine carcinoma (EP-NEC). This is the third orphan drug designation that Velyso® has received, following those from the U.S. Food and Drug Administration and the European Commission, marking a further expansion of its global regulatory recognition into major Asian markets. Source: https://finance.eastmoney.com/a/202609283885132814.html
- Source: drugdu
- 138
- September 29, 2026
Healthcare Facilities Symposium & Expo

、 Organiser： Austin International Medical Association Time：September 28-30, 2026 Address：501 S College St, Charlotte, NC 28202, USA Exhibition hall：CHARLOTTE CONVENTION CENTER Product range: ‌Medical Equipment‌: Medical equipment, electronic medical instruments, dental equipment ‌Testing, Analysis & Diagnostic Instruments‌: Testing, analysis and diagnostic instruments, monitoring instruments ‌Medical Consumables‌: Consumables, disposable products, cotton and linen medical textiles ‌Medical Furniture‌: Medical furniture ‌Assistive Products‌: Assistive products for people with disabilities ‌Nursing & Rehabilitation Equipment‌: Nursing and rehabilitation instruments ‌Cleaning, Disinfection & Sterilization Products‌: Cleaning, disinfection and sterilization products ‌Pharmaceuticals & Nutritional Health Products‌: Pharmaceuticals and nutritional health products ‌Medical Packaging‌: Medical packaging About Healthcare Facilities Symposium & Expo： Healthcare Facilities Symposium & Expo is one of the most important medical device exhibitions in the United States. It aims to create a multidisciplinary environment that inspires change through physical spaces and promotes better healthcare delivery. The previous edition of the Healthcare Facilities Symposium & ...
- Source: drugdu
- 108
- September 29, 2026
【EXPERT Q&A】The buyer said that the sample test has passed. How can the project be pushed to a trial order next?

Drugdu.com expert’s response: In pharmaceutical foreign trade, after sending out samples, the sentence that every salesperson most looks forward to seeing is probably: “Sample passed our test.” However, upon receiving this message, some sales representatives do not know how to follow up properly. They simply reply: “Great, looking forward to your order.” And then start waiting. Several days pass with no order from the client; a week later, they send another message: “Any update?” The client replies: “We are still discussing internally.” Gradually, the entire project grinds to a halt. A sample passing the test is certainly good news, but there is usually a noticeable gap between “qualified sample” and “formal procurement”. At this stage, what suppliers need to confirm is no longer whether the product is usable, but how the client plans to make the purchase. Confirm the purchase quantity and timeline right after sample approval The sample phase is meant to ...
- Source: drugdu
- 128
- September 28, 2026
【EXPERT Q&A】When a buyer makes an inquiry and only leaves the product name and country, which questions should be asked in the first round?

Drugdu.com expert’s response: In pharmaceutical foreign trade, it is very common to receive extremely short inquiries. For example: “Need Vitamin D3, Pakistan.” or “Looking for disposable syringe, UAE.” Sometimes buyers only leave the product name, country and email address, with no other information provided. There are no specifications, no quantity, no intended use, and no explanation of whether they are importers, distributors or end purchasers. Such inquiries cannot be directly judged as invalid. Some buyers are just testing whether the supplier will respond, some are sourcing goods for their end clients, and some have not sorted out their complete requirements yet. The focus of your first reply is not to quote immediately, nor to send all product catalogs and certificates at once. Instead, you should first ask for several most critical pieces of information. Confirm the specific specification or model first The product name alone provided by the buyer is ...
- Source: drugdu
- 130
- September 25, 2026
ExpoMedical, the Argentina Medical Devices, Hospital Supplies and Laboratory Equipment Exhibition

Organiser：ExpoMedical Time：September 23-25, 2026 Address：Av. Costanera R. Obligado and J. Salguero, Buenos Aires, Argentina Exhibition hall：Costa Salguero Exhibition Center Product range: Medical Equipment‌: Medical devices, electronic medical equipment, diagnostic instruments and equipment for all clinical departments, testing instruments, medical optical instruments, X-ray equipment, imaging equipment, scanning equipment, nuclear magnetic resonance, ultrasonic diagnosis, clinical laboratory analytical instruments, hemodialysis equipment, dental equipment, anesthesia and respiratory equipment, interventional diagnosis, dialysis equipment. ‌Medical Supplies‌: Disposable medical supplies, consumables, syringes, blood transfusion sets, sanitary cotton, adhesive bandages, masks, bandages, stethoscopes, medical ambulances, operating room supplies, work uniforms, medical kits, gloves, various types of medical scalpels, forceps, scissors, small electronic instruments, testing equipment, orthopedic technology, medical beds, surgical supplies, disinfection supplies, cleaning technology, ambulance service supplies, wound dressings. ‌First Aid Supplies‌: First aid equipment, emergency equipment, pharmaceutical products, drugs, infusions, disinfectants, blood derivatives, nutritional products, dermatological drugs, veterinary drugs, bandages, medical dressings, surgical ...
- Source: drugdu
- 124
- September 24, 2026
What Are Buyers Looking For, and What Are Suppliers Focused On?

From September 16–18, CPHI & PMEC Shenzhen 2026 brought together pharmaceutical companies and industry professionals across APIs, excipients, finished formulations, pharmaceutical machinery, and other segments of the pharma value chain. The Drugdu.com team was on-site throughout the three-day event. We met familiar faces, connected with new companies across different sectors, talked with buyers looking for products and suppliers, and sat down with companies exploring new ways to expand their international business. After three days of conversations, one thing stood out: What matters is not simply how many people you meet at an exhibition, but what buyers and suppliers are actually looking for. Buyers Are Looking for More Than Products “Do you have suppliers for this product?” “Are there other Chinese manufacturers we can compare?” “Can we contact the manufacturer directly?” Many of our conversations with buyers started with a specific product. But finding the product is only the first step. ...
- Source: drugdu
- 199
- September 23, 2026
【EXPERT Q&A】How to apply for a medical device registration certificate?

Drugdu.com expert’s response: For medical device registration certificate application, the first step is not to immediately prepare a large stack of materials, but to determine which risk class the product belongs to. In China, medical devices are categorized into Class I, Class II and Class III based on their risk levels. Class I devices are subject to record-filing management, while Class II and Class III devices are subject to registration management. The “medical device registration certificate application” that enterprises usually refer to mainly targets Class II and Class III products. For domestic Class III devices, as well as imported Class II and Class III devices, the National Medical Products Administration (NMPA) is responsible for the review, evaluation and approval. Domestic Class II devices are generally registered under the charge of provincial drug regulatory authorities. After clarifying the product classification, you need to confirm the registration applicant and the production relationship. ...
- Source: drugdu
- 131
- September 23, 2026
Ho Chi Minh City Medical Devices, Analytical Biochemistry and Laboratory Equipment Exhibition

Organiser：Adpex JSC Time：September 22-24, 2026 Address：Lawrence S. Ting Building, 801 Nguyen Van Linh Parkway, District 7, Ho Chi Minh City, Vietnam Exhibition hall：Saigon Exhibition and Convention Center (SECC) Product range: ‌Medical Products Exhibition Area‌: Medical equipment and instruments, medical consumables, medical dressings, surgical equipment, ambulance equipment, diagnostic equipment and supplies, ophthalmic instruments and equipment, otolaryngology equipment, dental equipment and supplies, medical reagents and equipment, healthcare products and devices, medical institution and laboratory technical equipment, medical information and technical exchange, beauty instruments. ‌Analytical Instruments Exhibition Area‌: Optical analytical instruments, mass spectrometers, spectrometers, chromatographs, spectrum analyzers, frequency spectrum analyzers, electrochemical analytical instruments, radiographic analytical instruments, gas chromatographs, liquid chromatographs, thermal analytical instruments, portable instruments, surface analytical instruments, nuclear analytical instruments, elemental analytical instruments, process analytical instruments, compositional analytical instruments, injection analytical instruments, general-purpose analytical instruments. ‌Laboratory Equipment Exhibition Area‌: Laboratory instruments and equipment, laboratory automation and accessories, optical instruments and equipment, ...
- Source: drugdu
- 108
- September 22, 2026

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.